Concept Life Sciences is a Malvern Panalytical company. We are a contract research and manufacturing organization, based in the UK.
We offer a comprehensive range of discovery and development services and analytical solutions across the pharmaceutical, biotechnology and agrochemical sectors. We cover all activities from target to clinic, including discovery chemistry, biology, DMPK, bioanalysis, toxicology and GMP manufacturing.
Concept Life Sciences was formed in 2014, following the merger of Scientific Analysis Laboratories (SAL), Agenda1 Analytical Services, Peakdale Molecular, CXR Biosciences and Resource & Environmental Consultants (REC). Since then, Concept Life Sciences has expanded through a mix of organic growth and targeted acquisition - most recently Aquila Biomedical in 2018. Today, we are home to over 250 employees, working from five laboratories across the UK.
Concept Life Sciences has an outstanding leadership team with many years of experience in the industry and a proven track record for success. Many members of the team are leading scientists with long and distinguished careers in their chosen field of expertise.
- Mark Carnegie-Brown - President
Dr Mark Carnegie-Brown joined as President in June 2019 and brings a wealth of leadership experience from within the life science & health science industry.
- Michael Hall - Finance Director
- Dr Ben Cliff – VP Operations
Ben joined Concept Life Sciences in 2018 and headed up operations within the Analytical and Development Services division, in 2020 he led the commercial integration project between Malvern Panalytical and CLS, resuming Operational oversight of the CLS labs in late 2020. Prior to this, Ben gained extensive commercial and scientific business leadership experience by leading multiple sites within a Global CRO in the Pharmaceutical, chemical and material science sectors.
- Helen Inch - HR Director
Helen joined Concept Life Sciences in August 2020 following 20+ years’ experience working at an HR senior leadership level for several customer service businesses.
- David Leese - VP Chemistry Services
David has spent his career to date in the CRO sector, starting at the bench and progressing through to his current leadership role where he has operational and functional responsibility for chemistry services within Concept Life Sciences.
- Clare Doris - VP, Biology Services
Clare has over 20 years’ experience of working in the CRO sector, progressing from bench scientist, through team management, and then joining a start-up (Aquila BioMedical) at the point of spin-out from The University of Edinburgh, as Chief Operating Officer.
- David Fengas - Director of CMC Services
David joined Concept Life Sciences in 2010 following seven years at Pfizer as a Team Leader supporting various therapeutic areas including allergy & respiratory and pain.
- Graeme Clark - VP Bioanalysis and DMPK
Graeme leads the Bioanalytical and DMPK teams that support investigative toxicology and drug discovery customer programs, as well as standalone regulatory bioanalytical functions.
- Steven Woolley - Director of Analytical Services
Steve joined Concept Life Sciences in July 2019 after spending over 25 years in the life science and Contract Research Organisation Industries.
- Tilly Bingham - VP of Science
Matilda Bingham is a drug discoverer with over 18 years’ experience in the pharmaceutical R&D sector in ‘Large Pharma’ (Organon, Schering-Plough, MSD) and Biotech (Redx Pharma).
- Victoria Light - Head of Program Management
Victoria is an experienced leader with a strong track record of project management and commercial process improvement within the CRO industry.
- Lesley Sutherland - VP of Quality
Lesley joined Concept Life Sciences in Sep 2019 as VP of Quality to oversee the quality systems at all sites and implement a cohesive benchmark system.